Literature DB >> 30879729

Risk Factors for Complications in Children with Staphylococcus aureus Bacteremia.

Rana F Hamdy1, Daniele Dona2, Marni B Jacobs3, Jeffrey S Gerber2.   

Abstract

OBJECTIVES: To determine risk factors for complications in children with Staphylococcus aureus (S aureus) bacteremia, including methicillin resistance. STUDY
DESIGN: Single center, retrospective cohort study of children ≤18 years of age hospitalized with S aureus bacteremia. We compared clinical characteristics and outcomes between those with methicillin-sensitive S aureus (MSSA) and methicillin-resistant S aureus (MRSA) bacteremia. Multivariate regression models identified risk factors associated with developing complications and with longer duration of bacteremia.
RESULTS: We identified 394 episodes of S aureus bacteremia, 279 (70.8%) with MSSA, and 115 (29.2%) with MRSA. Primary site of infection was catheter-related in 34%, musculoskeletal in 30%, skin/soft tissue in 10.2%, pneumonia in 6.4%, and endovascular in 6.6%. Eight children (2.0%) died within 30 days because of S aureus bacteremia, 15 (3.5%) had recurrence within 30 days, and 38 (9.6%) had complications including septic emboli or a metastatic focus of infection. Methicillin resistance was associated with development of a complication (aOR 3.31; 95% CI 1.60-6.85), and catheter-related infections were less likely to be associated with a complication (aOR 0.40; 95% CI 0.15-1.03). In a Poisson regression analysis on duration of bacteremia, methicillin resistance, musculoskeletal infection, endovascular infection, black race, and delayed intervention for source control were significantly associated with longer duration of bacteremia.
CONCLUSIONS: In this cohort of children with S aureus bacteremia, MRSA infections ere associated with longer duration of bacteremia and a higher likelihood of complications.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MRSA; Staphylococcus aureus; bacteremia; children

Year:  2019        PMID: 30879729     DOI: 10.1016/j.jpeds.2018.12.002

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  A Multicenter Analysis of Changes in Pediatric Antibiotic Susceptibilities Among Staphylococcus aureus and Pseudomonas aeruginosa Isolates: 2014-2018.

Authors:  Jeremy S Stultz; Emily Benefield; Kelley R Lee; Ferras Bashqoy; Amy L Pakyz
Journal:  J Pediatr Pharmacol Ther       Date:  2022-05-09

2.  Contemporary Trends in Global Mortality of Sepsis Among Young Infants Less Than 90 Days: A Systematic Review and Meta-Analysis.

Authors:  Ming Ying Gan; Wen Li Lee; Bei Jun Yap; Shu Ting Tammie Seethor; Rachel G Greenberg; Jen Heng Pek; Bobby Tan; Christoph Paul Vincent Hornik; Jan Hau Lee; Shu-Ling Chong
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

Review 3.  Acute infectious osteomyelitis in children: new treatment strategies for an old enemy.

Authors:  Sabrina Congedi; Chiara Minotti; Carlo Giaquinto; Liviana Da Dalt; Daniele Donà
Journal:  World J Pediatr       Date:  2020-05-11       Impact factor: 2.764

4.  Hospital epidemiology and antimicrobial susceptibility of isolated methicillin-resistant Staphylococcus aureus: a one-year retrospective study at a tertiary care center in Thailand.

Authors:  Palapun Waitayangkoon; Achitpol Thongkam; Tanawat Benjamungkalarak; Muanpetch Rachayon; Aphisit Thongthaisin; Tanittha Chatsuwan; Arsa Thammahong; Direkrit Chiewchengchol
Journal:  Pathog Glob Health       Date:  2020-05-07       Impact factor: 2.894

5.  Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections.

Authors:  Ethan Canty; Benjamin Carnahan; Tara Curley; Emily Anususinha; Rana F Hamdy; Jessica E Ericson
Journal:  Pediatr Infect Dis J       Date:  2021-05-01       Impact factor: 2.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.